347 related articles for article (PubMed ID: 7788824)
1. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
[TBL] [Abstract][Full Text] [Related]
2. [Registration of peranesthetic cases of malignant hyperthermia in France. An update].
Jacquot C; Stieglitz P; Kozak-Reiss G; Krivosic-Horber R; Laxenaire MC; Lienhart A; Nivoche Y
Ann Fr Anesth Reanim; 1988; 7(6):524-34. PubMed ID: 3223647
[TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia.
Ben Abraham R; Adnet P; Glauber V; Perel A
Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
[TBL] [Abstract][Full Text] [Related]
4. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Sato N; Brum JM; Mitsumoto H; DeBoer GE
Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
Mortier W; Breucking E
Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
[TBL] [Abstract][Full Text] [Related]
6. Muscle biopsy for malignant hyperthermia screening in children.
Ummenhofer W; Roesslein R; Sutter PM; Moser N; Kern C; Urwyler A
Eur J Pediatr Surg; 1997 Oct; 7(5):259-62. PubMed ID: 9402480
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of the contracture test for diagnosing malignant hyperthermia in a Brazilian population sample: a retrospective observational study.
de Mello JM; Andrade PV; Santos JM; Oliveira ASB; Vainzof M; do Amaral JLG; Almeida da Silva HC
Braz J Anesthesiol; 2023; 73(2):145-152. PubMed ID: 35835312
[TBL] [Abstract][Full Text] [Related]
8. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
[TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia.
Halliday NJ
J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results].
Breucking E; Mortier W
Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202
[TBL] [Abstract][Full Text] [Related]
11. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
Allen GC; Rosenberg H; Fletcher JE
Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777
[TBL] [Abstract][Full Text] [Related]
12. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.
Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F
Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia.
Ording H; Hedengran AM; Skovgaard LT
Acta Anaesthesiol Scand; 1991 Nov; 35(8):711-6. PubMed ID: 1763590
[TBL] [Abstract][Full Text] [Related]
14. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
Schuster F; Müller-Reible CR
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
[TBL] [Abstract][Full Text] [Related]
15. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
[TBL] [Abstract][Full Text] [Related]
16. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
17. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
[TBL] [Abstract][Full Text] [Related]
18. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
[TBL] [Abstract][Full Text] [Related]
19. [Lack of sensitivity to per-anesthetic malignant hyperthermia in 32 patients who developed neuroleptic malignant syndrome].
Bello N; Adnet P; Saulnier F; Lestavel P; Adnet-Bonte C; Reyford H; Etchrivi T; Tavernier B; Krivosic-Horber R
Ann Fr Anesth Reanim; 1994; 13(5):663-8. PubMed ID: 7733515
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features of malignant hyperthermia crisis].
Cornet C; Moeller R; Laxenaire MC
Ann Fr Anesth Reanim; 1989; 8(5):435-43. PubMed ID: 2516711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]